The global Medical Nuclide Products market was valued at US$ 11150 million in 2025 and is anticipated to reach US$ 20510 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Medical Nuclide Products Market

Medical nuclide products refer to medical preparations or devices containing radioactive isotopes, which achieve diagnostic or therapeutic functions through the radiation released by their decay. Such products must strictly comply with radioactive safety standards and are widely used in the field of nuclear medicine. For example, imaging agents used in diagnosis assist in disease detection through gamma-ray imaging, and iodine-131 and lutetium-177 used in treatment destroy diseased tissues through targeted radiation. Their production, quality control and clinical use are subject to the dual constraints of national nuclear safety regulations and the drug regulatory system to ensure patient safety and the effectiveness of diagnosis and treatment.

The global medical nuclide products market is being driven by the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions, which require precise diagnostic imaging and targeted radiopharmaceutical therapies. Technological advancements in nuclear imaging modalities like PET and SPECT, combined with the increasing adoption of theranostic approaches, have significantly expanded clinical applications for medical nuclides. In addition, favorable government initiatives to promote nuclear medicine infrastructure, and increasing investment in radioisotope production facilities, particularly in developing regions, are further accelerating market growth.

Despite its potential, the medical nuclide products market faces several challenges. The short half-life of many radioisotopes requires localized and timely production, which puts pressure on logistics and supply chain networks, especially in geographically dispersed regions. Regulatory complexities surrounding the handling, transport, and storage of radioactive materials also increase operational burden. Moreover, a global shortage of key isotopes like Mo-99, and limited access to cyclotrons and nuclear reactors in many countries, hampers consistent supply. High costs and the scarcity of trained nuclear medicine professionals further constrain market expansion in certain areas.

This report delivers a comprehensive overview of the global Medical Nuclide Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Nuclide Products. The Medical Nuclide Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Medical Nuclide Products market comprehensively. Regional market sizes by Type, by Application, by Product, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Medical Nuclide Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Medical Nuclide Products Market Report

Report Metric	Details
Report Name	Medical Nuclide Products Market
Accounted market size in 2025	US$ 11150 million
Forecasted market size in 2032	US$ 20510 million
CAGR	9.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Technetium-99m Fluorine-18 Gallium-68 Iodine-123 Indium-111 Copper-64 Xenon-133 Iodine-131 Yttrium-90 Lutetium-177 Strontium-89 Samarium-153 Radium-223 Iodine-125 Other
Segment by Product	Therapeutic Nuclear Medicine Diagnostic Nuclear Medicine
Segment by Application	Cancer Cardiovascular Disease Bone and Joint Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Saide Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Product, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Medical Nuclide Products companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Medical Nuclide Products Market growing?

Ans: The Medical Nuclide Products Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Medical Nuclide Products Market size in 2032?

Ans: The Medical Nuclide Products Market size in 2032 will be US$ 20510 million.

Who are the main players in the Medical Nuclide Products Market report?

Ans: The main players in the Medical Nuclide Products Market are Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Saide Biotechnology

What are the Application segmentation covered in the Medical Nuclide Products Market report?

Ans: The Applications covered in the Medical Nuclide Products Market report are Cancer, Cardiovascular Disease, Bone and Joint Disease, Other

What are the Type segmentation covered in the Medical Nuclide Products Market report?

Ans: The Types covered in the Medical Nuclide Products Market report are Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Indium-111, Copper-64, Xenon-133, Iodine-131, Yttrium-90, Lutetium-177, Strontium-89, Samarium-153, Radium-223, Iodine-125, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Medical Nuclide Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Technetium-99m

1.2.3 Fluorine-18

1.2.4 Gallium-68

1.2.5 Iodine-123

1.2.6 Indium-111

1.2.7 Copper-64

1.2.8 Xenon-133

1.2.9 Iodine-131

1.2.10 Yttrium-90

1.3 Market by Product

1.3.1 Global Medical Nuclide Products Market Size Growth Rate by Product: 2021 vs 2025 vs 2032

1.3.2 Therapeutic Nuclear Medicine

1.3.3 Diagnostic Nuclear Medicine

1.4 Market by Application

1.4.1 Global Medical Nuclide Products Market Growth by Application: 2021 vs 2025 vs 2032

1.4.2 Cancer

1.4.3 Cardiovascular Disease

1.4.4 Bone and Joint Disease

1.4.5 Other

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Medical Nuclide Products Market Perspective (2021–2032)

2.2 Global Medical Nuclide Products Growth Trends by Region

2.2.1 Global Medical Nuclide Products Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Medical Nuclide Products Historic Market Size by Region (2021–2026)

2.2.3 Medical Nuclide Products Forecasted Market Size by Region (2027–2032)

2.3 Medical Nuclide Products Market Dynamics

2.3.1 Medical Nuclide Products Industry Trends

2.3.2 Medical Nuclide Products Market Drivers

2.3.3 Medical Nuclide Products Market Challenges

2.3.4 Medical Nuclide Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Medical Nuclide Products Players by Revenue

3.1.1 Global Top Medical Nuclide Products Players by Revenue (2021–2026)

3.1.2 Global Medical Nuclide Products Revenue Market Share by Players (2021–2026)

3.2 Global Top Medical Nuclide Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Medical Nuclide Products Revenue

3.4 Global Medical Nuclide Products Market Concentration Ratio

3.4.1 Global Medical Nuclide Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Medical Nuclide Products Revenue in 2025

3.5 Global Key Players of Medical Nuclide Products Head Offices and Areas Served

3.6 Global Key Players of Medical Nuclide Products, Products and Applications

3.7 Global Key Players of Medical Nuclide Products, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Medical Nuclide Products Breakdown Data by Type

4.1 Global Medical Nuclide Products Historic Market Size by Type (2021–2026)

4.2 Global Medical Nuclide Products Forecasted Market Size by Type (2027–2032)

5 Medical Nuclide Products Breakdown Data by Application

5.1 Global Medical Nuclide Products Historic Market Size by Application (2021–2026)

5.2 Global Medical Nuclide Products Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Medical Nuclide Products Market Size (2021–2032)

6.2 North America Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Medical Nuclide Products Market Size by Country (2021–2026)

6.4 North America Medical Nuclide Products Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Medical Nuclide Products Market Size (2021–2032)

7.2 Europe Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Medical Nuclide Products Market Size by Country (2021–2026)

7.4 Europe Medical Nuclide Products Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Medical Nuclide Products Market Size (2021–2032)

8.2 Asia-Pacific Medical Nuclide Products Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Medical Nuclide Products Market Size by Region (2021–2026)

8.4 Asia-Pacific Medical Nuclide Products Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Medical Nuclide Products Market Size (2021–2032)

9.2 Latin America Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Medical Nuclide Products Market Size by Country (2021–2026)

9.4 Latin America Medical Nuclide Products Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Medical Nuclide Products Market Size (2021–2032)

10.2 Middle East & Africa Medical Nuclide Products Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Medical Nuclide Products Market Size by Country (2021–2026)

10.4 Middle East & Africa Medical Nuclide Products Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Medical Nuclide Products Introduction

11.1.4 Cardinal Health Revenue in Medical Nuclide Products Business (2021–2026)

11.1.5 Cardinal Health Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Medical Nuclide Products Introduction

11.2.4 GE Healthcare Revenue in Medical Nuclide Products Business (2021–2026)

11.2.5 GE Healthcare Recent Development

11.3 Lantheus Medical Imaging

11.3.1 Lantheus Medical Imaging Company Details

11.3.2 Lantheus Medical Imaging Business Overview

11.3.3 Lantheus Medical Imaging Medical Nuclide Products Introduction

11.3.4 Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (2021–2026)

11.3.5 Lantheus Medical Imaging Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Medical Nuclide Products Introduction

11.4.4 Bayer Revenue in Medical Nuclide Products Business (2021–2026)

11.4.5 Bayer Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Medical Nuclide Products Introduction

11.5.4 Eli Lilly Revenue in Medical Nuclide Products Business (2021–2026)

11.5.5 Eli Lilly Recent Development

11.6 Bracco Imaging

11.6.1 Bracco Imaging Company Details

11.6.2 Bracco Imaging Business Overview

11.6.3 Bracco Imaging Medical Nuclide Products Introduction

11.6.4 Bracco Imaging Revenue in Medical Nuclide Products Business (2021–2026)

11.6.5 Bracco Imaging Recent Development

11.7 Curium Pharma

11.7.1 Curium Pharma Company Details

11.7.2 Curium Pharma Business Overview

11.7.3 Curium Pharma Medical Nuclide Products Introduction

11.7.4 Curium Pharma Revenue in Medical Nuclide Products Business (2021–2026)

11.7.5 Curium Pharma Recent Development

11.8 Jubilant Pharmova

11.8.1 Jubilant Pharmova Company Details

11.8.2 Jubilant Pharmova Business Overview

11.8.3 Jubilant Pharmova Medical Nuclide Products Introduction

11.8.4 Jubilant Pharmova Revenue in Medical Nuclide Products Business (2021–2026)

11.8.5 Jubilant Pharmova Recent Development

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Details

11.9.2 Aurobindo Pharma Business Overview

11.9.3 Aurobindo Pharma Medical Nuclide Products Introduction

11.9.4 Aurobindo Pharma Revenue in Medical Nuclide Products Business (2021–2026)

11.9.5 Aurobindo Pharma Recent Development

11.10 Novartis

11.10.1 Novartis Company Details

11.10.2 Novartis Business Overview

11.10.3 Novartis Medical Nuclide Products Introduction

11.10.4 Novartis Revenue in Medical Nuclide Products Business (2021–2026)

11.10.5 Novartis Recent Development

11.11 Siemens

11.11.1 Siemens Company Details

11.11.2 Siemens Business Overview

11.11.3 Siemens Medical Nuclide Products Introduction

11.11.4 Siemens Revenue in Medical Nuclide Products Business (2021–2026)

11.11.5 Siemens Recent Development

11.12 NTP Radioisotopes

11.12.1 NTP Radioisotopes Company Details

11.12.2 NTP Radioisotopes Business Overview

11.12.3 NTP Radioisotopes Medical Nuclide Products Introduction

11.12.4 NTP Radioisotopes Revenue in Medical Nuclide Products Business (2021–2026)

11.12.5 NTP Radioisotopes Recent Development

11.13 ANSTO

11.13.1 ANSTO Company Details

11.13.2 ANSTO Business Overview

11.13.3 ANSTO Medical Nuclide Products Introduction

11.13.4 ANSTO Revenue in Medical Nuclide Products Business (2021–2026)

11.13.5 ANSTO Recent Development

11.14 Polatom

11.14.1 Polatom Company Details

11.14.2 Polatom Business Overview

11.14.3 Polatom Medical Nuclide Products Introduction

11.14.4 Polatom Revenue in Medical Nuclide Products Business (2021–2026)

11.14.5 Polatom Recent Development

11.15 China Isotope & Radiation

11.15.1 China Isotope & Radiation Company Details

11.15.2 China Isotope & Radiation Business Overview

11.15.3 China Isotope & Radiation Medical Nuclide Products Introduction

11.15.4 China Isotope & Radiation Revenue in Medical Nuclide Products Business (2021–2026)

11.15.5 China Isotope & Radiation Recent Development

11.16 Yantai Dongcheng Pharmaceutical

11.16.1 Yantai Dongcheng Pharmaceutical Company Details

11.16.2 Yantai Dongcheng Pharmaceutical Business Overview

11.16.3 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Introduction

11.16.4 Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (2021–2026)

11.16.5 Yantai Dongcheng Pharmaceutical Recent Development

11.17 Saide Biotechnology

11.17.1 Saide Biotechnology Company Details

11.17.2 Saide Biotechnology Business Overview

11.17.3 Saide Biotechnology Medical Nuclide Products Introduction

11.17.4 Saide Biotechnology Revenue in Medical Nuclide Products Business (2021–2026)

11.17.5 Saide Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

China Isotope & Radiation

Lantheus Medical Imaging

Jubilant Pharmova

Novartis

Yantai Dongcheng Pharmaceutical

Saide Biotechnology

List of Tables

Table 1. Global Medical Nuclide Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Technetium-99m

Table 3. Key Players of Fluorine-18

Table 4. Key Players of Gallium-68

Table 5. Key Players of Iodine-123

Table 6. Key Players of Indium-111

Table 7. Key Players of Copper-64

Table 8. Key Players of Xenon-133

Table 9. Global Medical Nuclide Products Market Size Growth Rate by Product (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Therapeutic Nuclear Medicine

Table 11. Key Players of Diagnostic Nuclear Medicine

Table 12. Global Medical Nuclide Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 13. Global Medical Nuclide Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Medical Nuclide Products Market Size by Region (US$ Million), 2021–2026

Table 15. Global Medical Nuclide Products Market Share by Region (2021–2026)

Table 16. Global Medical Nuclide Products Forecasted Market Size by Region (US$ Million), 2027–2032

Table 17. Global Medical Nuclide Products Market Share by Region (2027–2032)

Table 18. Medical Nuclide Products Market Trends

Table 19. Medical Nuclide Products Market Drivers

Table 20. Medical Nuclide Products Market Challenges

Table 21. Medical Nuclide Products Market Restraints

Table 22. Global Medical Nuclide Products Revenue by Players (US$ Million), 2021–2026

Table 23. Global Medical Nuclide Products Market Share by Players (2021–2026)

Table 24. Global Top Medical Nuclide Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Medical Nuclide Products Revenue, 2025

Table 25. Ranking of Global Top Medical Nuclide Products Companies by Revenue (US$ Million) in 2025

Table 26. Global 5 Largest Players Market Share by Medical Nuclide Products Revenue (CR5 and HHI), 2021–2026

Table 27. Global Key Players of Medical Nuclide Products, Headquarters and Area Served

Table 28. Global Key Players of Medical Nuclide Products, Products and Applications

Table 29. Global Key Players of Medical Nuclide Products, Date of General Availability (GA)

Table 30. Mergers and Acquisitions, Expansion Plans

Table 31. Global Medical Nuclide Products Market Size by Type (US$ Million), 2021–2026

Table 32. Global Medical Nuclide Products Revenue Market Share by Type (2021–2026)

Table 33. Global Medical Nuclide Products Forecasted Market Size by Type (US$ Million), 2027–2032

Table 34. Global Medical Nuclide Products Revenue Market Share by Type (2027–2032)

Table 35. Global Medical Nuclide Products Market Size by Application (US$ Million), 2021–2026

Table 36. Global Medical Nuclide Products Revenue Market Share by Application (2021–2026)

Table 37. Global Medical Nuclide Products Forecasted Market Size by Application (US$ Million), 2027–2032

Table 38. Global Medical Nuclide Products Revenue Market Share by Application (2027–2032)

Table 39. North America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 40. North America Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026

Table 41. North America Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032

Table 42. Europe Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. Europe Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026

Table 44. Europe Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032

Table 45. Asia-Pacific Medical Nuclide Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 46. Asia-Pacific Medical Nuclide Products Market Size by Region (US$ Million), 2021–2026

Table 47. Asia-Pacific Medical Nuclide Products Market Size by Region (US$ Million), 2027–2032

Table 48. Latin America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 49. Latin America Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026

Table 50. Latin America Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032

Table 51. Middle East & Africa Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Middle East & Africa Medical Nuclide Products Market Size by Country (US$ Million), 2021–2026

Table 53. Middle East & Africa Medical Nuclide Products Market Size by Country (US$ Million), 2027–2032

Table 54. Cardinal Health Company Details

Table 55. Cardinal Health Business Overview

Table 56. Cardinal Health Medical Nuclide Products Product

Table 57. Cardinal Health Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 58. Cardinal Health Recent Development

Table 59. GE Healthcare Company Details

Table 60. GE Healthcare Business Overview

Table 61. GE Healthcare Medical Nuclide Products Product

Table 62. GE Healthcare Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 63. GE Healthcare Recent Development

Table 64. Lantheus Medical Imaging Company Details

Table 65. Lantheus Medical Imaging Business Overview

Table 66. Lantheus Medical Imaging Medical Nuclide Products Product

Table 67. Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 68. Lantheus Medical Imaging Recent Development

Table 69. Bayer Company Details

Table 70. Bayer Business Overview

Table 71. Bayer Medical Nuclide Products Product

Table 72. Bayer Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 73. Bayer Recent Development

Table 74. Eli Lilly Company Details

Table 75. Eli Lilly Business Overview

Table 76. Eli Lilly Medical Nuclide Products Product

Table 77. Eli Lilly Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 78. Eli Lilly Recent Development

Table 79. Bracco Imaging Company Details

Table 80. Bracco Imaging Business Overview

Table 81. Bracco Imaging Medical Nuclide Products Product

Table 82. Bracco Imaging Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 83. Bracco Imaging Recent Development

Table 84. Curium Pharma Company Details

Table 85. Curium Pharma Business Overview

Table 86. Curium Pharma Medical Nuclide Products Product

Table 87. Curium Pharma Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 88. Curium Pharma Recent Development

Table 89. Jubilant Pharmova Company Details

Table 90. Jubilant Pharmova Business Overview

Table 91. Jubilant Pharmova Medical Nuclide Products Product

Table 92. Jubilant Pharmova Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 93. Jubilant Pharmova Recent Development

Table 94. Aurobindo Pharma Company Details

Table 95. Aurobindo Pharma Business Overview

Table 96. Aurobindo Pharma Medical Nuclide Products Product

Table 97. Aurobindo Pharma Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 98. Aurobindo Pharma Recent Development

Table 99. Novartis Company Details

Table 100. Novartis Business Overview

Table 101. Novartis Medical Nuclide Products Product

Table 102. Novartis Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 103. Novartis Recent Development

Table 104. Siemens Company Details

Table 105. Siemens Business Overview

Table 106. Siemens Medical Nuclide Products Product

Table 107. Siemens Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 108. Siemens Recent Development

Table 109. NTP Radioisotopes Company Details

Table 110. NTP Radioisotopes Business Overview

Table 111. NTP Radioisotopes Medical Nuclide Products Product

Table 112. NTP Radioisotopes Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 113. NTP Radioisotopes Recent Development

Table 114. ANSTO Company Details

Table 115. ANSTO Business Overview

Table 116. ANSTO Medical Nuclide Products Product

Table 117. ANSTO Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 118. ANSTO Recent Development

Table 119. Polatom Company Details

Table 120. Polatom Business Overview

Table 121. Polatom Medical Nuclide Products Product

Table 122. Polatom Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 123. Polatom Recent Development

Table 124. China Isotope & Radiation Company Details

Table 125. China Isotope & Radiation Business Overview

Table 126. China Isotope & Radiation Medical Nuclide Products Product

Table 127. China Isotope & Radiation Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 128. China Isotope & Radiation Recent Development

Table 129. Yantai Dongcheng Pharmaceutical Company Details

Table 130. Yantai Dongcheng Pharmaceutical Business Overview

Table 131. Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product

Table 132. Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 133. Yantai Dongcheng Pharmaceutical Recent Development

Table 134. Saide Biotechnology Company Details

Table 135. Saide Biotechnology Business Overview

Table 136. Saide Biotechnology Medical Nuclide Products Product

Table 137. Saide Biotechnology Revenue in Medical Nuclide Products Business (US$ Million), 2021–2026

Table 138. Saide Biotechnology Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Medical Nuclide Products Picture

Figure 2. Global Medical Nuclide Products Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Medical Nuclide Products Market Share by Type: 2025 vs 2032

Figure 4. Technetium-99m Features

Figure 5. Fluorine-18 Features

Figure 6. Gallium-68 Features

Figure 7. Iodine-123 Features

Figure 8. Indium-111 Features

Figure 9. Copper-64 Features

Figure 10. Xenon-133 Features

Figure 11. Iodine-131 Features

Figure 12. Yttrium-90 Features

Figure 13. Global Medical Nuclide Products Market Size Comparison by Product (US$ Million), 2021–2032

Figure 14. Therapeutic Nuclear Medicine Features

Figure 15. Diagnostic Nuclear Medicine Features

Figure 16. Global Medical Nuclide Products Market Size by Application (US$ Million), 2021–2032

Figure 17. Global Medical Nuclide Products Market Share by Application: 2025 vs 2032

Figure 18. Cancer Case Studies

Figure 19. Cardiovascular Disease Case Studies

Figure 20. Bone and Joint Disease Case Studies

Figure 21. Other Case Studies

Figure 22. Medical Nuclide Products Report Years Considered

Figure 23. Global Medical Nuclide Products Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Medical Nuclide Products Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Medical Nuclide Products Market Share by Region: 2025 vs 2032

Figure 26. Global Medical Nuclide Products Market Share by Players in 2025

Figure 27. Global Medical Nuclide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Medical Nuclide Products Revenue in 2025

Figure 29. North America Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Medical Nuclide Products Market Share by Country (2021–2032)

Figure 31. United States Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Medical Nuclide Products Market Share by Country (2021–2032)

Figure 35. Germany Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Medical Nuclide Products Market Share by Region (2021–2032)

Figure 43. China Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Medical Nuclide Products Market Share by Country (2021–2032)

Figure 51. Mexico Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Medical Nuclide Products Market Share by Country (2021–2032)

Figure 55. Israel Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Medical Nuclide Products Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Cardinal Health Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 59. GE Healthcare Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 60. Lantheus Medical Imaging Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 61. Bayer Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 62. Eli Lilly Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 63. Bracco Imaging Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 64. Curium Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 65. Jubilant Pharmova Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 66. Aurobindo Pharma Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 67. Novartis Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 68. Siemens Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 69. NTP Radioisotopes Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 70. ANSTO Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 71. Polatom Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 72. China Isotope & Radiation Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 73. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 74. Saide Biotechnology Revenue Growth Rate in Medical Nuclide Products Business (2021–2026)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions